TrademarkDir
Serial #88839998
LIVE

Serial Number

88839998

Owner

AMICUS THERAPEUTICS, INC.

Attorney

Matthew P. Hintz, Esq.

Filing Date

Mar 19, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

Serial #88839998 Trademark

Serial Number: 88839998 • Registration: 6317076

Serial #88839998 is a trademark filed by AMICUS THERAPEUTICS, INC. on March 19, 2020. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AMICUS THERAPEUTICS, INC.

Philadelphia, PA 19104

Entity Type: 03

Trademark Details

Filing Date

March 19, 2020

Registration Date

April 6, 2021

Published for Opposition

July 14, 2020

Goods & Services

Providing health information in the field of rare genetic diseases; Providing medical information in the field of rare genetic diseases

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 6, 2026 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 6, 2021 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 2, 2021 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 28, 2021 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 10, 2021 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 10, 2021 AITU
USE AMENDMENT FILED
Jan 28, 2021 IUAF
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 28, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 28, 2021 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 28, 2021 COAR
TEAS STATEMENT OF USE RECEIVED
Jan 23, 2021 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2020 CNSA
ASSIGNED TO EXAMINER
Jun 11, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 24, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2020 NWOS
NEW APPLICATION ENTERED
Mar 23, 2020 NWAP

Related Trademarks

More from this Owner

IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES

CRADLE OF CURES

CRADLE OF CURES

CRADLE OF CURES

CRADLE OF CURES

CRADLE OF CURES

CRADLE OF CURES

MYDAY

MYDAY